Etiopathogenesis And Classification
Pyogenic Liver Abscess
- Uncommon in healthy children; carries high mortality risk.
- Incidence higher in developing nations and immunocompromised states (chronic granulomatous disease, hyper-immunoglobulin E syndrome).
- Routes of hepatic invasion:
- Portal vein: Intra-abdominal sepsis, appendicitis, omphalitis, umbilical venous catheterization.
- Biliary tree: Cholangitis, choledochal cyst, biliary stricture, calculus.
- Hepatic artery: Systemic sepsis, endocarditis, osteomyelitis, bacteremia.
- Contiguous extension: Gallbladder, perinephric infections.
- Direct inoculation: Penetrating trauma.
- Cryptogenic: Unknown source.
Amebic Liver Abscess
- Most common extraintestinal manifestation of Entamoeba histolytica.
- Trophozoites invade colonic mucosa, reaching liver via portal circulation.
Microbiological Profile
| Abscess Type | Common Pathogens | Clinical Context |
|---|---|---|
| Pyogenic (Developed Nations) | Staphylococcus aureus | Most common; strongly associated with chronic granulomatous disease. |
| Pyogenic (Developing Nations) | Escherichia coli, Klebsiella pneumoniae | Most common gram-negative aerobes. |
| Pyogenic (Immunocompromised) | Serratia species, Aspergillus species | Chronic granulomatous disease. |
| Pyogenic (Mixed) | Anaerobes, Streptococcus, Enterobacter | Polymicrobial infections common; secondary to biliary/portal sepsis. |
| Amebic | Entamoeba histolytica | Endemic areas, travel history; presentation delays of months to years possible. |
Clinical Manifestations
| System | Signs And Symptoms |
|---|---|
| General | Fever, chills, malaise, fatigue, anorexia, weight loss. |
| Abdominal | Right upper quadrant pain, tender hepatomegaly. Jaundice remains uncommon. |
| Specific To Amebic | Right shoulder radiation. Epigastric/left shoulder pain in left lobe disease. Concurrent dysentery (10%). Localized swelling. |
| Complications | Spontaneous rupture into peritoneum, pericardium, pleura, bronchial tree. Metastatic spread to lungs/brain. |
Diagnostic Evaluation
| Modality | Findings And Utility |
|---|---|
| Laboratory | Leukocytosis, elevated erythrocyte sedimentation rate, hypoalbuminemia. Mildly elevated transaminases and alkaline phosphatase. |
| Ultrasonography | First-line modality. Evaluates size, number, rim thickness, liquefaction. Amebic displays hypoechoic mass with surrounding rim. |
| Computed Tomography | Required for complicated cases. Defines extent, localizes multiple lesions, detects gas bubbles. |
| Chest Radiograph | Elevated right hemidiaphragm, right pleural effusion, basilar atelectasis. |
| Microbiology | Blood cultures positive in 25-35% of pyogenic cases. Pus aspiration confirms diagnosis. |
| Amebic Assays | Serum enzyme-linked immunosorbent assay positive in >95%. Stool polymerase chain reaction highly sensitive/specific. Aspirate yields "anchovy sauce" pus. |
Management Protocol
Pyogenic Liver Abscess
- Pharmacotherapy: Initiate broad-spectrum intravenous antibiotics (piperacillin-tazobactam, ampicillin-sulbactam, or third-generation cephalosporin plus metronidazole or clindamycin). Adjust based on culture sensitivities. Duration 4-6 weeks (initial 2 weeks parenteral).
- Percutaneous Drainage: Ultrasound or computed tomography-guided needle aspiration/catheter drainage indicated for large abscesses (>5-7 cm), impending rupture (rim <1 cm), or failure to improve after 3-5 days of antibiotics.
- Surgical Intervention: Reserved for multiseptate/loculated abscesses failing percutaneous drainage, frank intraperitoneal rupture, biliary obstruction, or highly viscous pus.
Amebic Liver Abscess
- Pharmacotherapy: Nitroimidazole (metronidazole 30-50 mg/kg/day or tinidazole) for 7-10 days. Alternatively, dehydroemetine for 2 weeks.
- Luminal Eradication: Administer luminal amebicide (paromomycin, diloxanide furoate, or iodoquinol) for 7 days to eliminate colonic cysts and prevent transmission.
- Refractory Cases: Add daily chloroquine for 2-3 weeks for synergistic effect and enhanced abscess wall penetration.
- Aspiration: Indicated for large abscesses (>5-7 cm), failure of medical therapy, or imminent rupture risk (especially pericardial/left lobe).